Search research articles
Contact Us
Filters
Showing results (71-80 of 121) with videos related to
Page
of 13
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
January 28, 2014
Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics
Aziz Nazha, Hagop M Kantarjian, Vijaya R Bhatt, et al.
Leukemia & Lymphoma
|
June 22, 2017
Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)
Srinivasa R Sanikommu, Michael J Clemente, Peter Chomczynski, et al.
Leukemia
|
October 19, 2019
Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome
Jibran Durrani, Hassan Awada, Ashwin Kishtagari, et al.
Blood Cancer Journal
|
December 15, 2017
Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive care
Aziz Nazha, Mikkael A Sekeres, Rami Komrokji, et al.
Blood Cancer Journal
|
January 12, 2018
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, et al.
Cancer Cell
|
September 29, 2015
hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies
Miguel Gallardo, Hun Ju Lee, Xiaorui Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2017
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer
Remco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
Blood Advances
|
July 20, 2019
Distinct clinical and biological implications of <i>CUX1</i> in myeloid neoplasms
Mai Aly, Zubaidah M Ramdzan, Yasunobu Nagata, et al.
JCO Precision Oncology
|
October 31, 2019
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence
Aziz Nazha, Mikkael A Sekeres, Rafael Bejar, et al.
American Journal of Hematology
|
July 24, 2013
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia
Aziz Nazha, Hagop Kantarjian, Farhad Ravandi, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 121) with videos related to
Sort By:
Page
of 13
Clinical Lymphoma, Myeloma & Leukemia
|
January 28, 2014
Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics
Aziz Nazha, Hagop M Kantarjian, Vijaya R Bhatt, et al.
Leukemia & Lymphoma
|
June 22, 2017
Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)
Srinivasa R Sanikommu, Michael J Clemente, Peter Chomczynski, et al.
Leukemia
|
October 19, 2019
Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome
Jibran Durrani, Hassan Awada, Ashwin Kishtagari, et al.
Blood Cancer Journal
|
December 15, 2017
Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive care
Aziz Nazha, Mikkael A Sekeres, Rami Komrokji, et al.
Blood Cancer Journal
|
January 12, 2018
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, et al.
Cancer Cell
|
September 29, 2015
hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies
Miguel Gallardo, Hun Ju Lee, Xiaorui Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2017
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer
Remco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
Blood Advances
|
July 20, 2019
Distinct clinical and biological implications of <i>CUX1</i> in myeloid neoplasms
Mai Aly, Zubaidah M Ramdzan, Yasunobu Nagata, et al.
JCO Precision Oncology
|
October 31, 2019
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence
Aziz Nazha, Mikkael A Sekeres, Rafael Bejar, et al.
American Journal of Hematology
|
July 24, 2013
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia
Aziz Nazha, Hagop Kantarjian, Farhad Ravandi, et al.
Page
of 13